IPIC - the obesity pill stock Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC - the obesity pill stock

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ernie de la fuente who wrote (96)	9/27/1996 2:35:00 AM
From: Anthony Tran	of 113

Margaret and the Doughboy, The future potential competitor of IPIC are: Drug Manufacturer Stage of Development Lovan Ely Lilly Abandon Used to be a Key competitor of Redux . At one time 2 years ahead of Redux Sibutramine Knoll Phase 2-3 ,2-3 years before PLA CCK-A Agonist Fisons Phase I 7-10 years before PLA Leptin Amgen Phase I yet, 7- 10 years before PLA Orlistat Roche Phase III, 1997-1998? Launch CL 316243 Cyanamid Phase I, 7-10 years befoore PLA As you can see potential competitor of Redux are 2-10 years behind. The closest is Roche, the best scenario will be in 2 years. So your guys could sleep well because IPIC will go way up . I love to see short sellers pants start to drop specially for you Margaret.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next